https://scholars.lib.ntu.edu.tw/handle/123456789/161609
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor | 臺大醫院-腫瘤醫學部;臺大醫學院-腫瘤醫學研究所;臺大醫學院-癌症研究中心; | - |
dc.contributor.author | Ramalingam, Suresh S. | en |
dc.contributor.author | Yang, James Chih-Hsin | en |
dc.contributor.author | Lee, Chee Khoon | en |
dc.contributor.author | Kurata, Takayasu | en |
dc.contributor.author | Kim, Dong-Wan | en |
dc.contributor.author | John, Thomas | en |
dc.contributor.author | Nogami, Naoyuki | en |
dc.contributor.author | Ohe, Yuichiro | en |
dc.contributor.author | Rukazenkov, Yuri | en |
dc.contributor.author | Frewer, Paul | en |
dc.contributor.author | Cantarini, Mireille | en |
dc.contributor.author | Ghiorghiu, Serban | en |
dc.contributor.author | Janne, Pasi A. | en |
dc.creator | Ramalingam, Suresh S.;Yang, James Chih-Hsin;Lee, Chee Khoon;Kurata, Takayasu;Kim, Dong-Wan;John, Thomas;Nogami, Naoyuki;Ohe, Yuichiro;Rukazenkov, Yuri;Frewer, Paul;Cantarini, Mireille;Ghiorghiu, Serban;Janne, Pasi A. | en |
dc.creator | 楊志新 | zh-tw |
dc.date | 2015 | - |
dc.date.accessioned | 2017-06-27T09:01:23Z | - |
dc.date.accessioned | 2018-07-09T02:48:05Z | - |
dc.date.available | 2017-06-27T09:01:23Z | - |
dc.date.available | 2018-07-09T02:48:05Z | - |
dc.date.issued | 2015 | - |
dc.identifier.uri | http://ntur.lib.ntu.edu.tw//handle/246246/280168 | - |
dc.language | en-us | - |
dc.relation | J. Clin. Oncol., 33(15), | - |
dc.relation.ispartof | J. Clin. Oncol. | - |
dc.subject.classification | [SDGs]SDG3 | - |
dc.title | AZD9291, a mutant-selective EGFR inhibitor, as first-line treatment for EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): Results from a phase 1 expansion cohort. | - |
dc.relation.pages | - | - |
dc.relation.journalvolume | 33 | - |
dc.relation.journalissue | 15 | - |
item.fulltext | no fulltext | - |
item.grantfulltext | none | - |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。